121 related articles for article (PubMed ID: 38575303)
1.
Sarig K; Oxley S; Kalra A; Sobocan M; Fierheller CT; Sideris M; Gootzen T; Ferris M; Eeles RA; Evans DG; Quaife SL; Manchanda R
J Med Genet; 2024 Jun; 61(7):716-725. PubMed ID: 38575303
[TBL] [Abstract][Full Text] [Related]
2. Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community.
Yi H; Trivedi MS; Crew KD; Schechter I; Appelbaum P; Chung WK; Allegrante JP; Kukafka R
Public Health Genomics; 2024; 27(1):57-67. PubMed ID: 38402864
[TBL] [Abstract][Full Text] [Related]
3. Community attitudes towards a Jewish community BRCA1/2 testing program.
Cousens N; Kaur R; Meiser B; Andrews L
Fam Cancer; 2017 Jan; 16(1):17-28. PubMed ID: 27480161
[TBL] [Abstract][Full Text] [Related]
4. Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry.
Tennen RI; Laskey SB; Koelsch BL; McIntyre MH; Tung JY
Sci Rep; 2020 May; 10(1):7669. PubMed ID: 32376921
[TBL] [Abstract][Full Text] [Related]
5. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
Lehmann LS; Weeks JC; Klar N; Garber JE
Genet Med; 2002; 4(5):346-52. PubMed ID: 12394347
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women.
Patel S; Legood R; Evans DG; Turnbull C; Antoniou AC; Menon U; Jacobs I; Manchanda R
Am J Obstet Gynecol; 2018 Apr; 218(4):431.e1-431.e12. PubMed ID: 29288066
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
Manchanda R; Patel S; Antoniou AC; Levy-Lahad E; Turnbull C; Evans DG; Hopper JL; Macinnis RJ; Menon U; Jacobs I; Legood R
Am J Obstet Gynecol; 2017 Nov; 217(5):578.e1-578.e12. PubMed ID: 28690137
[TBL] [Abstract][Full Text] [Related]
8. The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.
Gal I; Gershoni Baruch R; Haber D; Dagan E; Eisenberg-Barzilai S; Zidan J; Friedman E
Fam Cancer; 2004; 3(1):11-4. PubMed ID: 15131400
[TBL] [Abstract][Full Text] [Related]
9. BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening.
Shkedi-Rafid S; Gabai-Kapara E; Grinshpun-Cohen J; Levy-Lahad E
Genet Med; 2012 Jul; 14(7):688-94. PubMed ID: 22481128
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of two population screening programmes for
Cousens NE; Tiller J; Meiser B; Barlow-Stewart K; Rowley S; Ko YA; Mahale S; Campbell IG; Kaur R; Bankier A; Burnett L; Jacobs C; James PA; Trainer A; Neil S; Delatycki MB; Andrews L
BMJ Open; 2021 Jun; 11(6):e041186. PubMed ID: 34172541
[TBL] [Abstract][Full Text] [Related]
11. Population-Based Study of Attitudes toward BRCA Genetic Testing among Orthodox Jewish Women.
Tang EY; Trivedi MS; Kukafka R; Chung WK; David R; Respler L; Leifer S; Schechter I; Crew KD
Breast J; 2017 May; 23(3):333-337. PubMed ID: 27900810
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Kemp Z; Turnbull A; Yost S; Seal S; Mahamdallie S; Poyastro-Pearson E; Warren-Perry M; Eccleston A; Tan MM; Teo SH; Turner N; Strydom A; George A; Rahman N
JAMA Netw Open; 2019 May; 2(5):e194428. PubMed ID: 31125106
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Manchanda R; Legood R; Burnell M; McGuire A; Raikou M; Loggenberg K; Wardle J; Sanderson S; Gessler S; Side L; Balogun N; Desai R; Kumar A; Dorkins H; Wallis Y; Chapman C; Taylor R; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
J Natl Cancer Inst; 2015 Jan; 107(1):380. PubMed ID: 25435542
[TBL] [Abstract][Full Text] [Related]
14. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
[TBL] [Abstract][Full Text] [Related]
15. Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
Manchanda R; Loggenberg K; Sanderson S; Burnell M; Wardle J; Gessler S; Side L; Balogun N; Desai R; Kumar A; Dorkins H; Wallis Y; Chapman C; Taylor R; Jacobs C; Tomlinson I; McGuire A; Beller U; Menon U; Jacobs I
J Natl Cancer Inst; 2015 Jan; 107(1):379. PubMed ID: 25435541
[TBL] [Abstract][Full Text] [Related]
16. Reproductive decision-making in young female carriers of a BRCA mutation.
Donnelly LS; Watson M; Moynihan C; Bancroft E; Evans DG; Eeles R; Lavery S; Ormondroyd E
Hum Reprod; 2013 Apr; 28(4):1006-12. PubMed ID: 23293217
[TBL] [Abstract][Full Text] [Related]
17. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
18. Cultural aspects of healthy BRCA carriers from two ethnocultural groups.
Navarro de Souza A; Groleau D; Loiselle CG; Foulkes WD; Wong N
Qual Health Res; 2014 May; 24(5):665-81. PubMed ID: 24692182
[TBL] [Abstract][Full Text] [Related]
19. Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
Lieberman S; Tomer A; Ben-Chetrit A; Olsha O; Strano S; Beeri R; Koka S; Fridman H; Djemal K; Glick I; Zalut T; Segev S; Sklair M; Kaufman B; Lahad A; Raz A; Levy-Lahad E
Genet Med; 2017 Jul; 19(7):754-762. PubMed ID: 27929526
[TBL] [Abstract][Full Text] [Related]
20. Familial communication and cascade testing among relatives of BRCA population screening participants.
Lieberman S; Lahad A; Tomer A; Koka S; BenUziyahu M; Raz A; Levy-Lahad E
Genet Med; 2018 Nov; 20(11):1446-1454. PubMed ID: 29595811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
